Sally Susman, Executive Vice President at Pfizer Inc, was reported to have engaged in a transaction involving the company's stock on September 12, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.

Sally Susman, Executive Vice President at Pfizer Inc, was reported to have engaged in a transaction involving the company's stock on September 12, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.